| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18 |
| filingDate |
1983-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12438527ca22beec1b9871ab8422f3d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf3b2264827921143bdeb7f4c214447 |
| publicationDate |
1983-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0093521-A2 |
| titleOfInvention |
Quinoline derivatives |
| abstract |
Compounds of the formula:-n wherein A stands for the radical -(CH 2 ) 2 - which may optionally be substituted by one or two (1-2C)alkyl radicals; Q stands for an oxygen or sulphur atom; R° stands for a (1-4C)alkyl, (1-4C)alkoxy or cyclopropyl radical; R' stands for a defined (3-4C)alkyl radical, a phenyl radical which may optionally bear a defined substituent, or a defined heteroaryl radical of 5 to 6 ring atoms; and R 2 and R 3 stand for hydrogen or a (1-2C)alkyl radical; and pharmaceutically-acceptable acid-addition salts thereof. Processes for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or cerrier. The compounds are 5-hydroxytryptamine antagonists. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0124208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5179107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1981341-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4576953-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5348962-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0153850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5559125-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1981341-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5190956-A |
| priorityDate |
1982-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |